STAT5B and neoplasm: Additionally, we report the small molecule inhibitor AC-4-130 inhibits both STAT5 and STAT3 activation in our experimental setting, significantly inhibiting tumor development in vivo and highlighting the added benefit of a dual STAT3/5 inhibition.